Bicyclic melatonin receptor agonists containing a ring-junction nitrogen: Synthesis, biological evaluation, and molecular modeling of the putative bioactive conformation

被引:31
作者
Elsner, J
Boeckler, F
Davidson, K
Sugden, D
Gmeiner, P
机构
[1] Univ Erlangen Nurnberg, Emil Fischer Ctr, Dept Med Chem, D-91052 Erlangen, Germany
[2] Kings Coll London, Sch Biomed Sci, Div Reprod Hlth Endocrinol & Dev, London SE1 1UL, England
基金
英国惠康基金;
关键词
melatonin receptor agonist; bioactive conformation; subtype selectivity; 7a-azaindole;
D O I
10.1016/j.bmc.2005.10.042
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Employing 1,3-dipolar cycloaddition for the synthesis of the 7a-azaindole nucleus, analogues of melatonin have been synthesized and tested against human and amphibian melatonin receptors. Introducing a phenyl substituent ill position 2 of the heterocyclic moiety significantly increased binding affinity to both the MT1 and MT2 receptors. Shifting the methoxy group from position 5 to 2 of the 7a-azaindole ring led to a substantial reduction of MT1 binding when MT2 recognition was maintained. We theoretically investigated the hypothesis whether the 2-methoxy function of the azamelatonin analogue 27 is able to mimic the 5-methoxy group of the neurohormone by directing its 2-methoxy function toward the methoxy binding site. DFT calculations and experimental binding differences of analogue compounds indicate that the energy gained by forming the methoxy-specific hydrogen-bond interaction should exceed the energy required for adopting ail alternative conformation. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1949 / 1958
页数:10
相关论文
共 40 条
[1]   Interactive SAR studies:: Rational discovery of super-potent and highly selective dopamine D3 receptor antagonists and partial agonists [J].
Bettinetti, L ;
Schlotter, K ;
Hübner, H ;
Gmeiner, P .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (21) :4594-4597
[2]   FAUC 213, a highly selective dopamine D4 receptor full antagonist, exhibits atypical antipsychotic properties in behavioural and neurochemical models of schizophrenia [J].
Boeckler, F ;
Russig, H ;
Zhang, WN ;
Löber, S ;
Schetz, J ;
Hübner, H ;
Ferger, B ;
Gmeiner, P ;
Feldon, J .
PSYCHOPHARMACOLOGY, 2004, 175 (01) :7-17
[3]   Attenuation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity by the novel selective dopamine D3-receptor partial agonist FAUC 329 predominantly in the nucleus accumbens of mice [J].
Boeckler, F ;
Leng, A ;
Mura, A ;
Bettinetti, L ;
Feldon, J ;
Gmeiner, P ;
Ferger, B .
BIOCHEMICAL PHARMACOLOGY, 2003, 66 (06) :1025-1032
[4]   Agomelatine.: Antidepressant, treatment of bipolar disorder, melatonin agonist/5-HT2C antagonist. [J].
Chilman-Blair, K ;
Castañer, J ;
Bayés, M ;
Silvestre, JS .
DRUGS OF THE FUTURE, 2003, 28 (01) :7-13
[5]   Mapping the melatonin receptor.: 5.: Melatonin agonists and antagonists derived from tetrahydrocyclopent[b]indoles, tetrahydrocarbazoles and hexahydrocyclohept[b]indoles [J].
Davies, DJ ;
Garratt, PJ ;
Tocher, DA ;
Vonhoff, S ;
Davies, J ;
Teh, MT ;
Sugden, D .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (04) :451-467
[6]   Molecular pharmacology, regulation and function of mammalian melatonin receptors [J].
Dubocovich, ML ;
Rivera-Bermudez, MA ;
Gerdin, MJ ;
Masana, MI .
FRONTIERS IN BIOSCIENCE-LANDMARK, 2003, 8 :D1093-D1108
[7]  
Frisch M.J., 1998, GAUSSIAN 98
[8]   MAPPING THE MELATONIN RECEPTOR .3. DESIGN AND SYNTHESIS OF MELATONIN AGONISTS AND ANTAGONISTS DERIVED FROM 2-PHENYLTRYPTAMINES [J].
GARRATT, PJ ;
JONES, R ;
TOCHER, DA ;
SUGDEN, D .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (07) :1132-1139
[9]   MAPPING THE MELATONIN RECEPTOR .1. THE 5-METHOXYL GROUP OF MELATONIN IS NOT AN ESSENTIAL REQUIREMENT FOR BIOLOGICAL-ACTIVITY [J].
GARRATT, PJ ;
JONES, R ;
ROWE, SJ ;
SUGDEN, D .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, 4 (13) :1555-1558
[10]   AZAINDOL-DERIVATIVES .2. SYNTHESIS AND ANALGESIC ACTIVITY OF PYRAZOLO[1,5A]PYRIDINES [J].
GMEINER, P ;
SCHUNEMANN, J .
ARCHIV DER PHARMAZIE, 1988, 321 (09) :517-520